Skip to main content
Premium Trial:

Request an Annual Quote

Lion s Q4 Revenues Slide; Sale of Bioinformatics Biz Expected by End of Summer

NEW YORK, July 29 (GenomeWeb News) - Lion Bioscience posted a nearly 70-percent decline in quarterly revenues for its fourth fiscal quarter ended March 31, 2005, according to full-year results that the company released today.  

 

According to these results, receipts fell to around €1.2 million ($1.46 million) for the quarter, from €3.9 million in the year-ago period.

 

The company reported €10 million in total revenues for its 2004/2005 fiscal year, a decline of nearly 50 percent from €19.7 million in the prior fiscal year, but in line with projected revenues of €8 million to €10 million for the current year.  

 

Due to the planned sale of its UK-based bioinformatics business, Lion reclassified all revenues and expenses related to this business as discontinued operations, with the prior-year figures adjusted accordingly, the company said.

 

In line with this reclassification, Lion reported adjusted total revenues of €200,000 for the 12 months ending March 31 compared with €300,000 in adjusted revenues for the prior fiscal year. These figures include only those revenues based on income from Lion's Cambridge, Mass., subsidiary.  

 

Lion said in a statement that "the sales process of the bioinformatics business started successfully" and that it expects to close a sale "before the summer break."

 

Lion said it narrowed its net loss for the year to €13.2 million from €20.8 million in the prior fiscal year.

 

The company had previously projected €10 million to €11 million in net losses for the year ended March 31.

 

Lion said that it held cash and cash equivalents, including marketable securities, of €25.6 million as of March 31.

 

Lion also postponed the announcement of its financial results for the period ending June 30 from Aug. 4 to Aug. 12.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.